Citadel Advisors’s Globavend GVH Stock Holding History

Citadel Advisors’s Portfolio GVH Stock Details GVH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-528	Closed	-$59.9K	–	13508
2025 Q1	$59.9K	Buy	+528	New	+$74K	﹤0.01%	12115
2024 Q3	–	Sell	-114	Closed	-$20.6K	–	14605
2024 Q2	$20.6K	Buy	+114	New	+$28.4K	﹤0.01%	12615

Other funds holding GVH

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

GTS Securities New York $2.83B AUM 21.76% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Citadel Advisors's GVH Position: Q2 2025 in Review

Citadel Advisors sold out of Globavend (GVH) in Q2 2025, closing a stake of 528 shares — an estimated $59.9K sold.

Citadel Advisors first reported a position in GVH in Q2 2024 and held it in 2 quarters. The position peaked at $59.9K in Q1 2025. 4 funds tracked by Wall St. Rank hold GVH as of Q2 2025.

Citadel Advisors reported no remaining Globavend position as of Q2 2025 after selling out during the quarter.
Citadel Advisors sold 528 Globavend shares in Q2 2025, an estimated $59.9K.
Citadel Advisors first reported a position in Globavend in Q2 2024 and held it in 2 quarters.
Citadel Advisors's Globavend position peaked at $59.9K in Q1 2025.
4 funds tracked by Wall St. Rank held Globavend as of Q2 2025.

Based on Citadel Advisors's 13F filing for Q2 2025, filed 14 Aug 2025.